FENOFIBRATE IMPROVES LIVER TESTS IN PRIMARY SCLEROSING CHOLANGITIS WITH INCOMPLETE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID

被引：0
|
作者：
Chazouilleres, Olivier [1 ,2 ]
Corpechot, Christophe [1 ,2 ]
Gaouar, Farid [1 ]
Poupon, Raoul [1 ,2 ]
机构：
[1] Hop St Antoine, APHP, Serv Hepatol, Ctr Reference Malad Inflammatoires Voies Biliaire, F-75571 Paris, France
[2] Univ Paris 06, Fac Med St Antoine, UMR S938, Paris, France
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
336
引用
收藏
页码：488A / 488A
页数：1
相关论文
共 50 条
  • [31] Medical treatment of primary sclerosing cholangitis: on the role of ursodeoxycholic acid
    Stiehl, A
    Benz, C
    Sauer, P
    Theilman, L
    BILE ACIDS IN HEPATOBILIARY DISEASES: BASIC RESEARCH AND CLINICAL APPLICATION, 1997, 93 : 306 - 314
  • [32] Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
    Namisaki, T.
    Fujinaga, Y.
    Moriya, K.
    Kitade, M.
    Kaji, K.
    Kawaratani, H.
    Seki, K.
    Takaya, H.
    Sato, S.
    Sawada, Y.
    Akahane, T.
    Yoshiji, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S224 - S224
  • [33] Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression
    Fujinaga, Yukihisa
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Kawaratani, Hideto
    Kaji, Kosuke
    Okura, Yasushi
    Seki, Kenichiro
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Akahane, Takemi
    Nishimura, Norihisa
    Sato, Shinya
    Shimozato, Naotaka
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Kubo, Takuya
    Furukawa, Masanori
    Yoshiji, Hitoshi
    HEPATOLOGY, 2017, 66 : 196A - 196A
  • [34] The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis
    Namisaki, Tadashi
    Fujinaga, Yukihisa
    Moriya, Kei
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2021, 51 (01) : 31 - 38
  • [35] norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response
    Trauner, Michael H.
    Fickert, Peter
    Hirschfield, Gideon
    Denk, Gerald
    Altorjay, Istvan
    Marschall, Hanns-Ulrich
    Farkkila, Martti A.
    Schramm, Christoph
    Spengler, Ulrich
    Chapman, Roger W.
    Bergquist, Annika
    Schrumpf, Erik
    Nevens, Frederik
    Halilbasic, Emina
    Greinwald, Roland
    Proels, Markus
    Manns, Michael P.
    HEPATOLOGY, 2016, 64 : 111A - 111A
  • [36] Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms
    Huang, Lin-Xiang
    Wang, Zi-Long
    Jin, Rui
    Chen, Hong-Song
    Feng, Bo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (11-12) : 1065 - 1078
  • [37] Ciprofibrate: a new option of fibrate for primary biliary cholangitis with incomplete response to ursodeoxycholic acid
    Guedes, Laura
    Braga, Michele Harriz
    Moutinho, Bruna Damasio
    Carrilho, Flair Jose
    Rachid Cancado, Eduardo Luiz
    JOURNAL OF HEPATOLOGY, 2020, 73 : S479 - S479
  • [38] Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy
    Holtmeier, J
    Leuschner, M
    Stiehl, A
    Klein, R
    Leuschner, U
    BILE ACIDS AND PREGNANCY, 2002, 129A : 70 - 74
  • [39] EFFECTS OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS
    RAEDSCH, R
    STIEHL, A
    KOMMERELL, B
    TRENDS IN BILE ACID RESEARCH, 1989, 52 : 367 - 371
  • [40] Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid
    Stojakovic, Tatjana
    Putz-Bankuti, Csilla
    Fauler, Guenter
    Scharnagl, Hubert
    Wagner, Martin
    Stadlbauer, Vanessa
    Gurakuqi, Gerald
    Stauber, Rudolf E.
    Maerz, Winfried
    Trauner, Michael
    HEPATOLOGY, 2007, 46 (03) : 776 - 784
12345